As compounds become more complex in nature and biological ingredients are more widely used, stability testing approaches must follow suit and provide flexibility for developers. According to market ...
The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, ...
In this article, experts discuss the fundamentals of dissolution testing and highlight the challenges that are surfacing as a result of the increasing numbers of poorly soluble molecules entering the ...
In today’s pharmaceutical environment, where compliance and speed-to-market are paramount, analytical method development and validation play a foundational role. From early research through to GMP ...
In April 2025, the U.S. Food and Drug Administration (FDA) released its Roadmap to Reducing Animal Testing in Preclinical Safety Studies—a landmark initiative that lays out a plan to make animal ...
In the rapidly evolving 2025 consumer packaged goods (CPG) landscape, where market pressures demand faster, smarter decision making, breakthrough innovations don’t happen in isolation. They succeed in ...
A rare moment of bipartisan progress has emerged with the Senate’s unanimous passage of the FDA Modernization Act 3.0, ...
Researchers at the Technical University of Munich (TUM) have developed a method for diagnosing urinary tract infections that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback